CUAMC
COAG

China Universal Asset Management Company’s Hemab Therapeutics COAG Stock Holding History

China Universal Asset Management Company’s Portfolio COAG Stock Details COAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Buy
+3,600
New +$99.3K 0.01% 391

Other funds holding COAG

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

China Universal Asset Management Company's COAG Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Hemab Therapeutics (COAG) in Q2 2026: 3,600 shares worth $132K. The stake represents 0.01% of the portfolio and ranks #391 among its holdings.

4 funds tracked by Wall St. Rank hold COAG as of Q2 2026.

  • China Universal Asset Management Company held 3,600 shares of Hemab Therapeutics worth $132K as of Q2 2026.
  • Hemab Therapeutics was a new China Universal Asset Management Company position in Q2 2026.
  • Hemab Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #391 holding.
  • 4 funds tracked by Wall St. Rank held Hemab Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.